How A Chemist (Allegedly) Made $3.6 Million Through Insider Trading

The SEC is charging a chemist for the FDA with insider trading. Basically, they say that Cheng Yi Liang knew about upcoming drug decisions and then traded ahead of them.

The FDA even produced this trade chart, going back to 2006, explaining the trades.


NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at